Delivery Order SPE2DB24D1007-SPE2DB25FCCPA
- Not listed
- The Defense Logistics Agency awarded a $2,603.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is an unset-aside delivery order, awarded through competitive procurement, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a $4,165.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery under a non-competitive set-aside arrangement and is scheduled for completion by July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds a substantial $999.999 billion...
- The Defense Logistics Agency awarded a delivery order valued at $2,185.80 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, was competitively awarded without set-aside restrictions. The product will be delivered to AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $4,167.89 for the supply of Repatha 140 mg/mL SureClick auto-injector medication. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents a competitively awarded transaction under...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $2,033.64 contract is for the provision of Repatha 140 mg/mL SureClick injectable medication. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,050.46 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Repatha 140 mg/mL SureClick medication. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to...
- On July 22, 2025, the Defense Logistics Agency awarded a delivery order contract valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitive, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by July 23, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.53 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pharmaceutical products. This firm fixed price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Repatha 140 mg/mL SureClick medication. The $1,298.23 order has a completion date of February 14, 2024 and was awarded on February 13, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCPADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,524.72 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, was competitively selected for this delivery order based on its established capability to meet federal procurement requirements and its role as a prime vendor within the DLA Medical Supply Chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/22/25 |